Prevalence of neutralising antibodies to interferon-beta and clinical response in Chinese patients with relapsing multiple sclerosis

BACKGROUND: There are no data on neutralising antibodies to interferon-beta and its clinical implications in Chinese patients with multiple sclerosis (MS). OBJECTIVES: The objectives of this study were to investigate the prevalence of neutralising antibodies among Chinese patients with relapsing MS...

Descripción completa

Detalles Bibliográficos
Autores principales: Lau, Alexander Y, Ip, WK, Au, Cheryl, Lau, KK, Wong, Winnie, Yip, KK, Yeung, Jonas, Li, SH, Li, Patrick, Lee, Ryan, Siu, Deyond, Abrigo, Jill, Wong, Adrian, Mok, Vincent, Chan, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Original Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5637981/
https://www.ncbi.nlm.nih.gov/pubmed/29051830
http://dx.doi.org/10.1177/2055217317733485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5637981/
https://www.ncbi.nlm.nih.gov/pubmed/29051830
http://dx.doi.org/10.1177/2055217317733485

Ejemplares similares